A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Moving On - An RCT to Test Physical Therapy Education
- Status
- COMPLETED
- Phase
- NA
Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer
- Status
- COMPLETED
- Phase
- NA
ESP in Breast Surgery Due to Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
- Status
- RECRUITING
- Phase
- PHASE3
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- Status
- RECRUITING
- Phase
- NA
A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Taking AIM at Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Adherence Improving Self-Management Strategy (AIMS) in Breast Cancer Patients Using Adjuvant Endocrine Treatment (AET)
- Status
- UNKNOWN
- Phase
- NA
PREMs on PROMs in Breast Disease (PREMs_PROMs)
- Status
- COMPLETED
- Phase
- PHASE3
Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Dietary Advanced Glycation End Products, Inflammation and Oxidative Stress in Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
DNX-2440 for Resectable Colorectal Liver Metastasis
- Status
- SUSPENDED
- Phase
- PHASE1
Effects of Expectations and Body Image in Breast Reconstruction
- Status
- RECRUITING
- Phase
- N/A